Before the market opened on November 8, 2022, Bioventus, Inc. announced financial results for Q3 2022 that fell short of expectations. On this news, Bioventus, Inc. stock dropped more than 50%. Then, after the market closed on November 16, 2022, Bioventus disclosed that it would need additional time to file its Q3 2022 financial results due to, among other things, inadequate internal controls.
Shares of Bioventus, Inc. stock dropped more than 30% in intraday trading on November 17, 2022.
Contact our attorneys for a no-cost case evaluation.